What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Hepatocellular carcinoma, Internal medicine, Surgery, Radiology and Carcinoma.
He has included themes like Percutaneous ethanol injection, Survival rate, Cirrhosis, Tolerability and Prospective cohort study in his Hepatocellular carcinoma study.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
His Oncology research incorporates themes from Clinical trial and Lenvatinib.
The Surgery study combines topics in areas such as Adverse effect, Liver function and Radiofrequency ablation.
His work carried out in the field of Radiology brings together such families of science as Lesion and Thermal ablation.
His most cited work include:
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference (3541 citations)
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma (2143 citations)
- Hepatocellular carcinoma. (1254 citations)
What are the main themes of his work throughout his whole career to date?
Riccardo Lencioni mainly investigates Hepatocellular carcinoma, Radiology, Internal medicine, Surgery and Radiofrequency ablation.
His Hepatocellular carcinoma research incorporates elements of Nuclear medicine, Cirrhosis, Carcinoma and Percutaneous ethanol injection.
His Percutaneous ethanol injection research is multidisciplinary, incorporating perspectives in Survival rate and Transcatheter arterial chemoembolization.
His Radiology study combines topics from a wide range of disciplines, such as Lesion and Ablation.
His Internal medicine research integrates issues from Gastroenterology and Oncology.
The concepts of his Surgery study are interwoven with issues in Liver cancer, Liver function and Adverse effect.
He most often published in these fields:
- Hepatocellular carcinoma (52.53%)
- Radiology (48.82%)
- Internal medicine (28.62%)
What were the highlights of his more recent work (between 2012-2021)?
- Hepatocellular carcinoma (52.53%)
- Internal medicine (28.62%)
- Oncology (15.49%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Hepatocellular carcinoma, Internal medicine, Oncology, Sorafenib and Surgery.
The Liver cancer research Riccardo Lencioni does as part of his general Hepatocellular carcinoma study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
His Gastroenterology research extends to the thematically linked field of Internal medicine.
Riccardo Lencioni has researched Oncology in several fields, including Carcinoma, Randomized controlled trial and Adenocarcinoma.
Many of his research projects under Sorafenib are closely connected to Population with Population, tying the diverse disciplines of science together.
His Radiofrequency ablation study combines topics in areas such as Radiology, Ultrasound and Urology.
Between 2012 and 2021, his most popular works were:
- Hepatocellular carcinoma. (1254 citations)
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer (491 citations)
- Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. (221 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Riccardo Lencioni mostly deals with Hepatocellular carcinoma, Internal medicine, Oncology, Liver cancer and Sorafenib.
His research in Hepatocellular carcinoma intersects with topics in General surgery, Randomized controlled trial, Surgery and Ablation Techniques.
His work on Receptor as part of general Internal medicine research is often related to Kinase, thus linking different fields of science.
Riccardo Lencioni interconnects Carcinoma, Lenvatinib and Immunotherapy in the investigation of issues within Oncology.
His Liver cancer study which covers Ablation that intersects with Ablative case, Position paper and Stage.
His study looks at the relationship between Sorafenib and topics such as Prospective cohort study, which overlap with Tolerability.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
